Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
1550
Trial Sponsor
Clinical Trial Start Date
2009
0Primary Completion Date
2010
0Study Completion Date
2011
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Other0
Drug0
Intervention Name
ITCA 6500
Exenatide Injection0
Ex Inj/ITCA 6500
Interventional Trial Phase
Phase 20
Official Name
Phase 2 Study of ITCA 650 in Subjects With Type 2 Diabetes Mellitus0
Last Updated
April 13, 2015
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
None (Open Label)0
Study summary
The purpose of this study is to determine safety, efficacy and tolerability of various doses of ITCA 650 in subjects with type 2 diabetes.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
